文献速递血管炎

B淋巴细胞生成与B细胞成熟缺陷导致ANCA相关性血管炎中B细胞清除时间延长

Defects in B-lymphopoiesis and B-cell maturation underlie prolonged B-cell depletion in ANCA-associated vasculitis.
PubMed 文献 · Ann Rheum Dis · 2024-10-21

研究纳入91例ANCA相关性血管炎患者,通过光谱流式与质谱流式对外周及骨髓B细胞区室进行深度表型分析,并结合体外建模研究B细胞发育。结果发现初治患者过渡型B细胞数量低、骨髓B淋巴前体减少,体外B淋巴细胞生成完整但更慢且减少;部分患者RTX后过渡型B细胞出现但初始B细胞未补充,且RTX治疗患者B细胞BAFF受体表达低、体外对BAFF存活反应降低。结论认为RTX后B细胞清除延长提示B细胞缺陷被RTX揭示,骨髓B淋巴细胞生成受损导致外周B细胞恢复延迟,并可能被B细胞存活缺陷进一步加重。

要点

  • 初治ANCA相关性血管炎患者过渡型B细胞数量低,骨髓B淋巴前体减少。
  • 体外建模显示患者造血干细胞B淋巴细胞生成完整但更慢且未成熟B细胞发育减少。
  • 部分患者RTX后过渡型B细胞出现但未转化为初始B细胞补充,RTX治疗患者B细胞BAFF受体表达低、体外对BAFF存活反应降低。

核心结论

  • ANCA相关性血管炎患者RTX后B细胞清除延长提示存在被RTX揭示的B细胞缺陷。
  • 骨髓B淋巴细胞生成受损导致外周B细胞恢复延迟,并可能被B细胞存活缺陷进一步加重。
  • 研究结果有助于理解ANCA相关性血管炎发病机制,并可能对RTX再治疗schedule和免疫监测具有临床意义。

研究设计与样本

  • 研究纳入91例ANCA相关性血管炎患者,采用光谱流式和质谱流式对外周及骨髓B细胞区室进行深度表型分析。
  • 通过体外建模研究B细胞发育,并用定量PCR、western blot分析和体外试验研究BAFF受体的作用。

主要发现

  • 初治ANCA相关性血管炎患者过渡型B细胞数量低,提示B淋巴细胞生成受损。
  • 初治和RTX治疗患者骨髓中B淋巴前体减少。
  • 来自ANCA相关性血管炎造血干细胞的体外B淋巴细胞生成建模显示未成熟B细胞发育完整但更慢且减少。
  • 部分患者RTX后过渡型B细胞出现但未转化为初始B细胞补充,提示外周B细胞成熟受损。
  • RTX治疗ANCA相关性血管炎患者B细胞BAFF受体表达低,导致体外对BAFF的存活反应降低。

临床怎么用

  • 原文结论未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: B-cell depletion time after rituximab (RTX) treatment is prolonged in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) compared with other autoimmune diseases. We investigated central and peripheral B-cell development to identify the causes for the defect in B-cell reconstitution after RTX therapy. METHODS: We recruited 91 patients with AAV and performed deep phenotyping of the peripheral and bone marrow B-cell compartment by spectral flow and mass cytometry. B-cell development was studied by in vitro modelling and the role of BAFF receptor by quantitative PCR, western blot analysis and in vitro assays. RESULTS: Treatment-naïve patients with AAV showed low transitional B-cell numbers, suggesting impaired B-lymphopoiesis. We analysed bone marrow of treatment-naïve and RTX-treated patients with AAV and found reduced B-lymphoid precursors. In vitro modelling of B-lymphopoiesis from AAV haematopoietic stem cells showed intact, but slower and reduced immature B-cell development. In a subgroup of patients, after RTX treatment, the presence of transitional B cells did not translate in replenishment of naïve B cells, suggesting an impairment in peripheral B-cell maturation. We found low BAFF-receptor expression on B cells of RTX-treated patients with AAV, resulting in reduced survival in response to BAFF in vitro. CONCLUSIONS: Prolonged depletion of B cells in patients with AAV after RTX therapy indicates a B-cell defect that is unmasked by RTX treatment. Our data indicate that impaired bone marrow B-lymphopoiesis results in a delayed recovery of peripheral B cells that may be further aggravated by a survival defect of B cells. Our findings contribute to the understanding of AAV pathogenesis and may have clinical implications regarding RTX retreatment schedules and immunomonitoring after RTX therapy.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Thiel J, Schmidt FM, Lorenzetti R, et al. Defects in B-lymphopoiesis and B-cell maturation underlie prolonged B-cell depletion in ANCA-associated vasculitis. Ann Rheum Dis. 2024. PMID: 38851295. doi:10.1136/ard-2024-225587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。